MedTrace Logo

MBCT and CBT for Depression in Patients After Cancer: a Randomized Controlled Trial

NCT02619916 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2016-05-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether mindfulness-based cognitive therapy (MBCT) and cognitive behavioral therapy (CBT) are effective in reducing depressive symptoms in patients after cancer

Conditions

  • Depressive Symptoms

Interventions

BEHAVIORAL

Mindfulness-Based Cognitive Therapy (MBCT)

The intervention consists of 8 weekly individual sessions of MBCT. Each session will be administered individually and will last 60 minutes

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

The intervention consists of 8 weekly individual sessions of CBT. Each session will be administered individually and will last 60 minutes.

Sponsors & Collaborators

  • University of Groningen

    collaborator OTHER

  • Dutch Cancer Society

    collaborator OTHER

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Maya Schroevers, Dr. · University Medical Center Groningen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-09-30
Completion
2018-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619916 on ClinicalTrials.gov